SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-14-006259
Filing Date
2014-11-14
Accepted
2014-11-14 16:25:39
Documents
9
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q hbmk_10q.htm 10-Q 432383
2 CERTIFICATION hbmk_ex311.htm EX-31.1 9711
3 CERTIFICATION hbmk_ex321.htm EX-32.1 3019
  Complete submission text file 0001477932-14-006259.txt   3874315

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT hbmk-20140930.xml EX-101.INS 578506
5 XBRL TAXONOMY EXTENSION SCHEMA hbmk-20140930.xsd EX-101.SCH 42698
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hbmk-20140930_cal.xml EX-101.CAL 53781
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hbmk-20140930_def.xml EX-101.DEF 71473
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE hbmk-20140930_lab.xml EX-101.LAB 231129
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hbmk-20140930_pre.xml EX-101.PRE 171329
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53231 | Film No.: 141224585
SIC: 2834 Pharmaceutical Preparations